Advertisement
BD Bioscience
BD Bioscience

The Scientist

» pharmaceuticals and immunology

Most Recent

image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  

0 Comments

image: Drug Allergy in the Pocket

Drug Allergy in the Pocket

By | October 1, 2012

An HIV drug can bind to and alter the function of an immune molecule, causing a dangerous reaction in patients with a particular allele.

0 Comments

image: Mission: Possible

Mission: Possible

By | October 1, 2012

Cooperation, not competition, is the way forward.

1 Comment

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: Drugmakers Question FDA's Integrity

Drugmakers Question FDA's Integrity

By | September 26, 2012

Pharmaceutical and biotech companies ask the US Food and Drug Administration to ensure the independence of a third-party audit of its new drug program.

0 Comments

image: Rethinking Herbal Medicine

Rethinking Herbal Medicine

By | September 10, 2012

A phylogenetic study of traditional plant remedies could aid drug development.

21 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: FDA to Debate Starch Treatment

FDA to Debate Starch Treatment

By | August 31, 2012

The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Brain Keeps Watch During Sleep
  4. Locating Language within the Brain
Advertisement
BioRad
BioRad
Advertisement
Lab Quiz
Lab Quiz
RayBioTech
LI-COR Biosciences
LI-COR Biosciences